ArticleBMC cardiovascular disorders2025
Impact of eccentric and calcified plaque on bioresorbable scaffold and drug-eluting metallic stent expansion characteristics: a comparative intravascular ultrasound study.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPrevious studies have demonstrated greater lumen eccentricity and asymmetry with BRS compared to DES, but evidence regarding their expansion performance in complex lesions characterized by eccentric morphology or calcification remains scarce. This study aimed to compare and analyze the acute device performance of bioresorbable scaffolds (BRS) versus drug-eluting metallic stents (DES) using intravascular ultrasound (IVUS), and their expansion characteristics in eccentric and calcified lesions.
methodsIVUS analysis was performed pre- and post-procedure in 184 patients (48 BRS and 136 DES). Plaque eccentricity was quantified during pre-procedural using the plaque eccentricity index (PEI), with lesions stratified by calcification severity (no/mild: ≤90°; moderate/severe: >90° arc), while post-procedural device expansion performance was evaluated through three IVUS parameters including asymmetry index (AI), expansion ratio (ER) and eccentricity index (SEI).
resultsPre-procedural PEI demonstrated predictive value for post-procedural SEI and AI in both groups, yielding Areas Under the Curve (AUCs) of 0.811 and 0.773 for BRS, and 0.747 and 0.713 for DES. At high PEI, BRS showed significantly lower SEI than DES (0.87 vs. 0.91, P < 0.001). Moderate/severe calcification significantly increased AI in both BRS (0.36 vs. 0.32, P = 0.029) and DES (0.34 vs. 0.31, P = 0.025).
conclusionsEccentric distribution of plaque affects symmetry and uniformity of device expansion, and device eccentricity was more affected by the degree of pre-procedural plaque eccentricity in BRS than in DES. Moreover, calcified plaque further exacerbated post-procedural device asymmetry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.